lamivudine

Type: Keyphrase

Name: lamivudine

First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Kenya: Aids Patients Wait for Verdict on Drugs Law

Nairobi A group of people living with Aids will next month know whether a case they filed in court challenging a law they say denies them access to life-saving drugs will succeed or not.The group says the Anti-Counterfeit Act will interfere with the importation ... [Published Mar 19 2010 by AllAfrica.com]

Entities: HIV/AIDS, Kenya, Verdict

First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Osaka City University

Adding Adefovir (Hepsera) to Lamivudine (Epivir-HBV) Extends Biochemical Response, But May Cause Kidney Problems

Several nucleoside/nucleotide analogs are effective against , but when they are used alone, the virus can develop resistance relatively easily, thereby compromising long-term treatment success. Combining these agents, however, slows the emergence of ... [Published Mar 19 2010 by HIV and Hepatitis.com]

Entities: lamivudine, Kidney, Osaka City University, Graduate School, Hepatitis B Virus

First Reported Mar 06 2010 - Updated Mar 06 2010 - 1 Documents

Correlation of Inflammatory Biomarkers with the Framingham Coronary Risk Score in Antiretroviral-naïve HIV-1 Infected Patients

17th CROIConference on Retrovirusesand Opportunistic InfectionsSan Francisco CAFebruary 16-19, 2010 Reported by Jules Levin 17th CROI Feb 16-19 2010 SF Parul Patel1, Henry Zhao1, Lisa G Patel1, Amanda Peppercorn1, Paul Wannamaker1, Martin J Gartland2, ... [Published Mar 06 2010 by National AIDS Treatment Advocacy Project]

Entities: biomarker, Framingham (United States), Virology, Abacavir, Atazanavir

First Reported Mar 04 2010 - Updated Mar 04 2010 - 1 Documents

Research Report on Anti-HBV Drug Market

Sunfaith China Ltd, July 2009, Pages: 8DescriptionUnder the joint impact of four anti-HBV nucleoside drugs, i.e. lamivudine, adefovir dipivoxil, entecavir and Telbivudine, from 2001~2006, anti-HBV market of China’s sample hospitals in key cities grew ... [Published Mar 04 2010 by Research and Markets]

Entities: Telbivudine, Entecavir, lamivudine

First Reported Mar 03 2010 - Updated Mar 03 2010 - 1 Documents

Combination of Lamivudine and Adefovir Therapy in HBeAg-Positive Chronic Hepatitis B Patients With Poor Response to Adefovir Monotherapy

What is the effect of adding lamivudine to adefovir dipivoxil monotherapy in chronic hepatitis B patients who respond poorly to adefovir monotherapy?Journal of Viral Hepatitis ... [Published Mar 03 2010 by Medscape]

Entities: lamivudine, Hepatitis B, Viral Hepatitis

First Reported Mar 02 2010 - Updated Mar 02 2010 - 2 Documents

ACTG 5202 Shows Abacavir/lamivudine and Tenofovir/emtricitabine Provide Similar HIV Suppression at Low Viral Loads

ACTG 5202 was a randomized Phase 3b clinical trial comparing the effectiveness of commonly used ART components. Two nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) 'backbones' were tested in combination with both a non-nucleotide reverse ... [Published Mar 02 2010 by HIV and Hepatitis.com]

Entities: Abacavir, lamivudine, Suppression, Reverse Transcriptase Inhibitor, HIV/AIDS

First Reported Feb 26 2010 - Updated Feb 26 2010 - 1 Documents

Elvucitabine Versus 3TC in First-Line Regimens for 96 Weeks - see slides from poster below

17th CROIConference on Retrovirusesand Opportunistic InfectionsSan Francisco CAFebruary 16-19, 2010 17th Conference on Retroviruses and Opportunistic Infections, February 16-19, 2010, San Francisco Mark Mascolini Elvucitabine, a cytosine nucleoside analog, ... [Published Feb 26 2010 by National AIDS Treatment Advocacy Project]

Entities: Virology, lamivudine, Opportunistic Infections, Retrovirus

First Reported Feb 25 2010 - Updated Feb 25 2010 - 1 Documents

Abacavir/lamivudine combination in the treatment of HIV: a review

Sivasubramanian G et al. The frequency of the associated abacavir hypersensitivity syndrome has decreased substantially since the introduction of routine testing for the HLAB*5701 allele; the activity of the drug in HIVinfected persons with HIV RNA values ... [Published Feb 25 2010 by MDLinx]

Entities: lamivudine, Abacavir, HIV/AIDS

First Reported Feb 17 2010 - Updated Feb 18 2010 - 3 Documents

Gilead's Single-Tablet "Quad" Regimen for HIV Achieves a High Rate of Virologic Suppression in...

BusinessWire - Gilead Sciences, Inc. (Nasdaq:GILD) announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet 'Quad' regimen of elvitegravir, GS 9350 (cobicistat) and Truvada(R) (emtricitabine and tenofovir ... [Published Feb 17 2010 by Forbes.com]

Entities: HIV/AIDS, Efavirenz, ritonavir, lamivudine

First Reported Dec 03 2009 - Updated Dec 03 2009 - 1 Documents

ORIGINAL ARTICLE: AbacavirâLamivudine versus TenofovirâEmtricitabine for Initial HIV-1 Therapy

Background: The use of fixed-dose combination nucleoside reverse-transcriptase inhibitors (NRTIs) with a nonnucleoside reverse-transcriptase inhibitor or a ritonavir-boosted protease inhibitor is recommended as initial therapy in patients with human ... [Published Dec 03 2009 by NEJM â Collection Updates for Viral Diseases]

Entities: lamivudine, Nucleoside, immunodeficiency

First Reported Dec 01 2009 - Updated Dec 01 2009 - 1 Documents

Drug Patent Expirations in December 2009

Copyright © BiotechBlog.com , a product of thinkBiotech.com Drug Patent Expirations for December 2009 Tradename Applicant Generic Name Patent Number Patent Expiration MIGRANAL Valeant dihydroergotamine mesylate 5,169,849 Dec ... [Published Dec 01 2009 by Biotech Blog]

Entities: Patent, Abacavir, Guerbet, GlaxoSmithKline plc, lamivudine

First Reported Oct 10 2009 - Updated Oct 10 2009 - 1 Documents

US FDA Committee recommends approval of Pfizer's Selzentry for use in patients starting HIV therapy

Pfizer Inc. announced that the US Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee voted (10 to 4) to recommend the approval of Selzentry (maraviroc) tablets for use in treatment-nave adult patients with CCR5-tropic HIV-1 virus ... [Published Oct 10 2009 by PharmaBiz]

Entities: Pfizer Inc, HIV/AIDS, Food and Drug Administration

Quotes

...evidence of the benefit of initiating antiretroviral therapy during tuberculosis therapy in patients with HIV co-infection,' the authors concluded. "The findings also support recommendations by the [] and others for the integration of tuberculosis and HIV care." 100303 AD100351 AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation...

SOUTH AFRICA: Timing of Initiation of Antiretroviral Drugs During Tuberculosis Therapy [AEGIS - Mar 04 2010]

"The ACRG’s formation represents a prime example of a growing trend in pre-competitive collaboration in which large pharmaceutical companies combine their resources and expertise to rapidly increase knowledge of disease and disease processes" the collaborators said in a statement

Lilly, Merck, Pfizer Agree to Share Pre-Competitive Genomics Data on Lung, Gastric Cancers in Asia [GenomeWeb - Feb 24 2010]

More Content

sort by: Date \| Relevance
Add-on combination therapy with adefovir dipivo... [National AIDS Treatment Advocacy Project - Mar 20 2010]
Clinical Pharmacology at CROI 2010: Advances in... [National AIDS Treatment Advocacy Project - Mar 19 2010]
Bone/Osteoporosis/Vitamin D CROI 2010 Update [National AIDS Treatment Advocacy Project - Mar 19 2010]
Kenya: Aids Patients Wait for Verdict on Drugs Law [AllAfrica.com - Mar 19 2010]
Adding Adefovir (Hepsera) to Lamivudine (Epivir... [HIV and Hepatitis.com - Mar 19 2010]
Mylan Strengthens Portfolio With Generic Diabet... [Seeking Alpha - Mar 17 2010]
Mylan Strengthens Portfolio - Analyst Blog [Benzinga.com - Mar 17 2010]
Pathway Genomics' personal Genetic Health Repor... [News-Medical.Net - Mar 17 2010]
Reportlinker Adds Global Anti-Infectives Industry [Yahoo! Canada - Mar 08 2010]
Correlation of Inflammatory Biomarkers with the... [National AIDS Treatment Advocacy Project - Mar 06 2010]
Research Report on Anti-HBV Drug Market [Research and Markets - Mar 04 2010]
SOUTH AFRICA: Timing of Initiation of Antiretro... [AEGIS - Mar 04 2010]
Standard First Regimens Less Effective in US Bl... [National AIDS Treatment Advocacy Project - Mar 03 2010]
Combination of Lamivudine and Adefovir Therapy ... [Medscape - Mar 03 2010]
ACTG 5202 Shows Abacavir/lamivudine and Tenofov... [HIV and Hepatitis.com - Mar 02 2010]
ACTG 5202 Sub-study Finds Lipoatrophy Uncommon,... [HIV and Hepatitis.com - Mar 02 2010]
Plasma HIV Load Strongest Predictor of CSF Load... [National AIDS Treatment Advocacy Project - Feb 27 2010]
Elvucitabine Versus 3TC in First-Line Regimens ... [National AIDS Treatment Advocacy Project - Feb 26 2010]
Abacavir/lamivudine combination in the treatmen... [MDLinx - Feb 25 2010]
Lilly, Merck, Pfizer Agree to Share Pre-Competi... [GenomeWeb - Feb 24 2010]
ViiV Healthcare highlights S/GSK1349572, SELZEN... [News-Medical.Net - Feb 24 2010]
Bone & Limb Fat Outcomes in ACTG5202- More ... [National AIDS Treatment Advocacy Project - Feb 24 2010]
Mixed Findings on Value of Brain-Penetrating An... [National AIDS Treatment Advocacy Project - Feb 22 2010]
CROI (2010 Feb 16-19) Selected Neurocognitive A... [National AIDS Treatment Advocacy Project - Feb 22 2010]
ViiV Healthcare Presents New Data from HIV/AIDS... [Ulitzer - Feb 22 2010]
Antiretroviral drugs have variable effects on b... [Aidsmap - Feb 21 2010]
Maraviroc Does Not Boost Stalled CD4s in Virolo... [National AIDS Treatment Advocacy Project - Feb 21 2010]
Side Effect and CD4 Differences in Four ACTG 52... [National AIDS Treatment Advocacy Project - Feb 21 2010]
Bristol-Myers Squibb Media Statement on ACTG 5202 [National AIDS Treatment Advocacy Project - Feb 21 2010]
New Data on ISENTRESS (raltegravir) Presented a... [National AIDS Treatment Advocacy Project - Feb 21 2010]

Advanced Search Options

lamivudine